T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy

被引：1
|
作者：
Martin, Lisa J. [1 ]
Whitmore, James B. [1 ]
Shen, Rhine R. [1 ]
Neumann, Frank [1 ]
机构：
[1] Kite A Gilead Co, 2400 Broadway, Santa Monica, CA 90404 USA
来源：
BLOOD ADVANCES | 2024年 / 8卷 / 15期
关键词：
D O I：
10.1182/bloodadvances.2024013248
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4144 / 4148
页数：5
相关论文
共 50 条
  • [41] T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
    Storgard, Ryan
    Rejeski, Kai
    Perales, Miguel-Angel
    Goldman, Adam
    Shouval, Roni
    JAMA ONCOLOGY, 2024, 10 (06) : 826 - 828
  • [42] Chimeric Antigen Receptor T-Cell Therapy for T-Cell Acute Lymphocytic Leukemia
    Aldoss, Ibrahim
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2025, 23 (01) : 28 - 29
  • [43] Cardiotoxicities of Novel Therapies in Hematologic Malignancies: Chimeric Antigen Receptor T-Cell Therapy and Bispecific T-Cell Engager Therapy
    Marar, Rosalyn I. I.
    Abbasi, Muhannad Aboud
    Prathivadhi-Bhayankaram, Sruti
    Daryanani, Andres
    Villarraga, Hector
    Anavekar, Nandan
    Bhatt, Vijaya Raj
    Paludo, Jonas
    JCO ONCOLOGY PRACTICE, 2023, 19 (06) : 331 - +
  • [44] Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies
    Garcia-Prieto, Carlos A.
    Villanueva, Lorea
    Bueno-Costa, Alberto
    Davalos, Veronica
    Azucena Gonzalez-Navarro, Europa
    Juan, Manel
    Urbano-Ispizua, Alvaro
    Delgado, Julio
    Ortiz-Maldonado, Valentin
    Del Bufalo, Francesca
    Locatelli, Franco
    Quintarelli, Concetta
    Sinibaldi, Matilde
    Soler, Marta
    Castro de Moura, Manuel
    Ferrer, Gerardo
    Urdinguio, Rocio G.
    Fernandez, Agustin F.
    Fraga, Mario F.
    Bar, Diana
    Meir, Amilia
    Itzhaki, Orit
    Besser, Michal J.
    Avigdor, Abraham
    Jacoby, Elad
    Esteller, Manel
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (03): : 436 - 445
  • [45] Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare?
    Assi, Rita
    Salman, Huda
    CELLS, 2022, 11 (24)
  • [46] Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy
    Dai, Zhenyu
    Hu, Xuelian
    Jia, Xiangyin
    Liu, Jianwei
    Yang, Yongkun
    Niu, Panpan
    Hu, Guang
    Tan, Taochao
    Zhou, Jianfeng
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (08) : 5832 - 5847
  • [47] Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma A Review
    Locke, Frederick L.
    Go, William Y.
    Neelapu, Sattva S.
    JAMA ONCOLOGY, 2020, 6 (02) : 281 - 290
  • [48] Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: A Practical Review
    Strati, Paolo
    Gregory, Tara
    Majhail, Navneet S.
    Jain, Nitin
    JCO ONCOLOGY PRACTICE, 2023, 19 (09) : 706 - +
  • [49] Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies
    Polgarova, Kamila
    Otahal, Pavel
    Salek, Cyril
    Pytlik, Robert
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
    Gill, Saar
    June, Carl H.
    IMMUNOLOGICAL REVIEWS, 2015, 263 (01) : 68 - 89
12345